Delivery Order 36F79724D0101-36C24926N0658
Award Date 9/11/26
Potential Completion Date 12/14/26
Potential Value $364K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrenceville, Lawrence Township, NJ 08648, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI (lisocabtagene maraleucel) CAR T cell therapy under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is priced firm fixed price with no set-aside. Place of performance is Lawrenceville, New Jersey. The order is due for completion on September 17, 2026. The parent FSS vehicle, Pharmaceuticals and Drugs (FSS-61-IB), is a...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22, issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 30, 2026, for BREYANZI (lisocabtagene maraleucel), a chimeric antigen receptor T cell therapy, under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The GSA FSS-61-IB is a multiple-award IDIQ vehicle with a $12.278 billion ceiling extending through April 30, 2029, supporting specialized oncology and hematology...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI CAR T cell therapy for transplant under the Department of Veterans Affairs Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The order is firm fixed price with no set-aside designation. Place of performance is Lawrenceville, New Jersey, with an ultimate completion date of September 17, 2026. BREYANZI (lisocabtagene maraleucel) is a...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI CAR T transplant therapy under the Department of Veterans Affairs' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The order carries a firm fixed-price structure with no set-aside designation. Place of performance is Lawrenceville, New Jersey, with an ultimate completion date of September 17, 2026. BREYANZI (lisocabtagene maraleucel)...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $335,042.65 by Veterans Integrated Service Network 9 (VISN 9), a civilian component of the Department of Veterans Affairs, for the supply of BREYANZI CAR T cell therapy. This firm fixed-price delivery order, awarded on January 21, 2026, with an ultimate completion date of April 30, 2026, represents a child contract issued under Bristol-Myers Squibb's existing Federal Supply Schedule contract for Pharmaceuticals and Drugs...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer. The contract, valued at $670,085.30, is for the delivery of the emergency cancer therapy BREYANZI infusion. It is part of a larger Federal Supply Schedule (FSS) contract between the VA and Bristol-Myers Squibb, valued at $12,278,876,570.00 and running through April 2029. The FSS contract covers a range of pharmaceutical...
- Bristol-Myers Squibb Company received a delivery order modification worth $39,717.46 for ABECMA (idecabtagene vicleucel), a chimeric antigen receptor T cell therapy used to treat multiple myeloma and other hematologic malignancies. This delivery order, awarded on March 13, 2026, carries a total ceiling value of $378,650.30 and is scheduled for completion by September 12, 2026. The order was issued by Veterans Integrated Service Network 9 through Bristol-Myers Squibb's existing Federal Supply...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 (VA - VHA) awarded a $313,394.97 delivery order contract to Bristol-Myers Squibb Company Bristol Myers Squibb Division for the provision of BREYANZI. The prime contractor, Bristol-Myers Squibb Company, will perform under its Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order has a period of performance from January 30, 2023 through March 7, 2023.</p>
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer. The contract, valued at $338,932.84, is for the supply of ABECMA INJECTION, a chimeric antigen receptor (CAR) T cell therapy used for the treatment of certain types of cancer, including non-Hodgkin lymphoma and multiple myeloma. The contract supports the VA's Veterans Health Administration in providing advanced medical...
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $335,042.65 by Veterans Integrated Service Network 9 (VISN 9) for the purchase of transplant medication injections. This firm fixed-price delivery order, awarded on June 6, 2025, is scheduled for completion by August 8, 2025, with performance taking place in Lawrenceville, New Jersey. The award carries no set-aside designation, reflecting Bristol-Myers Squibb's status as a large for-profit pharmaceutical manufacturer....